对GC-MS的分子对接分析分析了来自Hedychium rubrum根茎的生物活性化合物,其中有四种蛋白质标
Ksh Sangeeta Devi1, M Damayanti Devi1, N Chetan Das1
1Manipur University, Manipur, India.
Bioinformation
|September 1, 2023
概括
根的根茎提取物显示出对导致尿路感染 (UTI) 的细菌具有显著的抗菌活性. 在 silico 研究表明其植物成分可以有效地准关键蛋白质,表明治疗潜力.
科学领域:
- 药理学 药理学是指药理学的学科.
- 植物化学 植物化学
- 计算生物学 计算生物学
背景情况:
- 红 (Hedychium rubrum) 是一种来自马尼普尔的传统药用植物,属树家族.
- 它的根茎提取物正在研究生物活动.
研究的目的:
- 选Hedychium rubrum根茎的甲醇提取物,以检测其抗菌活性.
- 使用气体染色学质谱法 (GC-MS) 识别生物活性化合物.
- 对已识别的化合物进行针对蛋白质标的in silico研究.
主要方法:
- 索克斯莱特提取物用于根茎提取物制备.
- 用于化合物识别的GC-MS分析.
- 在体外对5种引起尿路感染的细菌进行抗微生物检测.
- 在四个蛋白质目标上使用GOLD软件进行in silico分子对接.
- 在ADMET和TOPKAT研究中.
主要成果:
- 甲醇提取物在体外表现出显著的抗微生物活性,对抗Klebsiella pneumoniae,Pseudomonas aeruginosa,大肠杆菌,金黄色葡萄球菌和Enterococcus faecalis.
- 植物提取物显示出比积极对照更大的抑制区.
- GC-MS确定了几种生物活性化合物.
- 在 silico 研究表明,九个选定的植物成分具有与所有四个向蛋白质的受体位点结合的能力.
结论:
- 黑 (Hedychium rubrum) 根茎提取物对与尿路感染相关的细菌具有强大的抗菌特性.
- 已识别的植物成分显示出针对向蛋白质的药物开发的前景.
- 需要进一步的研究来探索Hedychium rubrum的治疗潜力.
更多相关视频
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
2.6K
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
322
相关概念视频
Ligand Binding Sites
12.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.9K
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Protein-Drug Binding: Determination Methods
233
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
233
The Equilibrium Binding Constant and Binding Strength
13.0K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
13.0K
Targets for Drug Action: Overview
6.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.4K
